Author(s): Nguyen PK, Riegler J, Wu JC
Abstract Share this page
Abstract Although cellular therapies hold great promise for the treatment of human disease, results from several initial clinical trials have not shown a level of efficacy required for their use as a first line therapy. Here we discuss how in vivo molecular imaging has helped identify barriers to clinical translation and potential strategies that may contribute to successful transplantation and improved outcomes, with a focus on cardiovascular and neurological diseases. We conclude with a perspective on the future role of molecular imaging in defining safety and efficacy for clinical implementation of stem cell therapies. Copyright © 2014 Elsevier Inc. All rights reserved.
This article was published in Cell Stem Cell
and referenced in Advancements in Genetic Engineering